Literature DB >> 11456567

Isolation and structure elucidation of Chlorofusin, a novel p53-MDM2 antagonist from a Fusarium sp.

S J Duncan1, S Grüschow, D H Williams, C McNicholas, R Purewal, M Hajek, M Gerlitz, S Martin, S K Wrigley, M Moore.   

Abstract

Wild-type p53 plays a crucial role in the prevention of cancer. Since dysfunction of p53 can be caused by increased levels of the protein MDM2, small molecules which antagonize the interaction between these two proteins have potential in cancer therapy. The discovery and structure determination of a fungal metabolite, chlorofusin, which antagonizes the p53/MDM2 interaction are reported.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11456567     DOI: 10.1021/ja002940p

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  32 in total

1.  The isolation and characterization of actinobacteria from dominant benthic macroinvertebrates endemic to Lake Baikal.

Authors:  Denis Axenov-Gribanov; Yuriy Rebets; Bogdan Tokovenko; Irina Voytsekhovskaya; Maxim Timofeyev; Andriy Luzhetskyy
Journal:  Folia Microbiol (Praha)       Date:  2015-09-07       Impact factor: 2.099

Review 2.  Targeting protein-protein interfaces using macrocyclic peptides.

Authors:  Meng Gao; Kui Cheng; Hang Yin
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

3.  Total synthesis, stereochemical reassignment, and absolute configuration of chlorofusin.

Authors:  Sang Yeul Lee; Ryan C Clark; Dale L Boger
Journal:  J Am Chem Soc       Date:  2007-07-19       Impact factor: 15.419

Review 4.  The re-emergence of natural products for drug discovery in the genomics era.

Authors:  Alan L Harvey; RuAngelie Edrada-Ebel; Ronald J Quinn
Journal:  Nat Rev Drug Discov       Date:  2015-01-23       Impact factor: 84.694

5.  Anoikis triggers Mdm2-dependent p53 degradation.

Authors:  Abhijit Ghosh; Tina Chunyuan Chen; Yvonne L Kapila
Journal:  Mol Cell Biochem       Date:  2010-06-26       Impact factor: 3.396

6.  Hoiamide D, a marine cyanobacteria-derived inhibitor of p53/MDM2 interaction.

Authors:  Karla L Malloy; Hyukjae Choi; Catherine Fiorilla; Fred A Valeriote; Teatulohi Matainaho; William H Gerwick
Journal:  Bioorg Med Chem Lett       Date:  2011-10-24       Impact factor: 2.823

7.  Cytotoxic effect of a non-peptidic small molecular inhibitor of the p53-HDM2 interaction on tumor cells.

Authors:  Wen-Dong Li; Mi-Juan Wang; Fang Ding; Da-Li Yin; Zhi-Hua Liu
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

Review 8.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

Review 9.  The isolation, total synthesis and structure elucidation of chlorofusin, a natural product inhibitor of the p53-mDM2 protein-protein interaction.

Authors:  Ryan C Clark; Sang Yeul Lee; Mark Searcey; Dale L Boger
Journal:  Nat Prod Rep       Date:  2009-04       Impact factor: 13.423

10.  Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53-HDM2 Protein-Protein Interaction.

Authors:  Peter M Fischer
Journal:  Int J Pept Res Ther       Date:  2006-03-15       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.